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background: HeartBeat Connections (HBC) is a telemedicine program that integrates with and complements primary care. Nurse- and dietitian-
led telephonic coaching focuses on controlling key cardiovascular disease (CVD) risk factors, and includes initiation/titration of dyslipidemia and 
hypertension medications.
methods: As part of the Heart of New Ulm project, electronic health records (EHR) were screened to identify and invite those with the metabolic 
syndrome or high Framingham Risk scores aged 40-79 (without CVD or diabetes) to enroll. Over the first six months following this invitation, EHR-
derived changes in LDL cholesterol, blood pressure, body mass index, and smoking were compared between those who did and did not participate.
results: Among the 1,035 invited adults, 333 (32%) enrolled in HBC. Mixed model analyses indicated enrollees and non-enrollees were 
comparable at baseline, and a significant group-by-time interaction was observed for LDL cholesterol (p=0.001). Over six months, non-enrollees 
dropped their LDL by 6.5 mg/dL, whereas HBC enrollees who completed < 4 and > 4 telephone encounters dropped their LDL by 4.5 and 16.1 mg/
dL, respectively. The proportion with LDL <100 mg/dL increased by 70% in enrollees (vs. 24% in non-enrollees).
conclusions: HBC significantly improved LDL in high CVD risk adults. Such real-world, systems-based innovations can serve as a platform to target 
and engage at-risk populations, thereby enhancing primary CVD care in rural and other underserved areas.
Non-enrollees (n = 702)
Enrollees with < 4 encounters
(n = 180)
Enrollees with > 4 encounters 
(n = 153)
Baseline Follow-up Change Baseline Follow-up Change Baseline Follow-up Change 
LDL (mg/dL ) 121.5 ± 1.6 115.0 ± 2.3 -6.5 ± 2.9*a 115.3 ± 2.6 110.8 ± 3.1 -4.5 ± 3.4a 126.9 ± 3.8 110.9 ± 3.1 -16.1 ± 3.4*b
Program goal (LDL 
<100)
24.6 30.3 5.7a 28.3 42.1 13.8ab 18.0 37.3 19.3*b
Systolic BP (mmHg) 130.1 ± 0.8 129.0 ± 0.9 -1.1 ± 1.3a 129.5 ± 1.3 129.1 ± 1.3 -0.4 ± 1.7a 128.3 ± 1.3 128.0 ± 1.4 -0.3 ± 1.7a
Diastolic BP (mmHg) 78.2 ± 0.5 75.8 ± 0.6 -2.4 ± 0.8*a 77.9 ± 0.8 76.2 ± 0.8 -1.7 ± 1.1a 77.4 ± 0.8 76.5 ± 0.9 -0.8 ± 1.1a
Controlled BP 
(<140/90)
71.7 74.3 3.4a 75.1 79.4 4.3a 78.9 74.5 -4.4a
BMI (kg/m2) 32.9 ± 0.2 32.8 ± 0.3 -0.1 ± 0.2a 33.7 ± 0.5 33.6 ± 0.5 -0.1 ± 0.2a 33.2 ± 0.5 32.9 ± 0.5 -0.3 ± 0.2a
Non-smoker 80.4 84.6 4.2a 82.9 94.4 11.5*b 88.4 92.2 3.8b
All outcomes were adjusted for age, sex, and days between baseline and follow-up measurements.
Continuous outcomes are reported as mean ±standard error, and categorical outcomes are reported as percent of sample.
* Significant (within-group) change between baseline and follow-up (p<0.05)
Change scores with different superscripts are significantly different from one another (p<0.05)
